The cost of typhoid illness in low- and middle-income countries, a scoping review of the literature
- PMID: 38917139
- PMCID: PMC11198801
- DOI: 10.1371/journal.pone.0305692
The cost of typhoid illness in low- and middle-income countries, a scoping review of the literature
Abstract
Typhoid fever is responsible for a substantial health burden in low- and middle-income countries (LMICs). New means of prevention became available with the prequalification of typhoid conjugate vaccines (TCV) by the World Health Organization (WHO) in 2018. Policymakers require evidence to inform decisions about TCV. The economic burden related to typhoid fever can be considerable, both for healthcare providers and households, and should be accounted for in the decision-making process. We aimed to understand the breadth of the evidence on the cost of typhoid fever by undertaking a scoping review of the published literature. We searched scientific databases with terms referring to typhoid fever cost of illness to identify published studies for the period January 1st 2000 to May 24th 2024. We also conferred with stakeholders engaged in typhoid research to identify studies pending completion or publication. We identified 13 published studies reporting empirical data for 11 countries, most of them located in Asia. The total cost of a typhoid episode ranged from $23 in India to $884 in Indonesia (current 2022 United States Dollar [USD]). Household expenditures related to typhoid fever were characterized as catastrophic in 9 studies. We identified 5 studies pending completion or publication, which will provide evidence for 9 countries, most of them located in Africa. Alignment in study characteristics and methods would increase the usefulness of the evidence generated and facilitate cross-country and regional comparison. The gap in evidence across regions should be mitigated when studies undertaken in African countries are published. There remains a lack of evidence on the cost to treat typhoid in the context of increasing antimicrobial resistance. Decision-makers should consider the available evidence on the economic burden of typhoid, particularly as risk factors related to antimicrobial resistance and climate change increase typhoid risk. Additional studies should address typhoid illness costs, using standardized methods and accounting for the costs of antimicrobial resistance.
Copyright: © 2024 Debellut et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
A Review of the Economic Evidence of Typhoid Fever and Typhoid Vaccines.Clin Infect Dis. 2019 Mar 7;68(Suppl 2):S83-S95. doi: 10.1093/cid/ciy1122. Clin Infect Dis. 2019. PMID: 30845334 Free PMC article. Review.
-
Introduction of Typhoid Conjugate Vaccines in Africa and Asia.Clin Infect Dis. 2019 Feb 15;68(Suppl 1):S27-S30. doi: 10.1093/cid/ciy878. Clin Infect Dis. 2019. PMID: 30767005 Free PMC article.
-
Cost of illness due to typhoid fever in five Asian countries.Trop Med Int Health. 2011 Mar;16(3):314-23. doi: 10.1111/j.1365-3156.2010.02711.x. Epub 2011 Jan 12. Trop Med Int Health. 2011. PMID: 21223462
-
Cost-effectiveness analysis of typhoid conjugate vaccines in five endemic low- and middle-income settings.Vaccine. 2017 Jun 14;35(27):3506-3514. doi: 10.1016/j.vaccine.2017.05.001. Epub 2017 May 17. Vaccine. 2017. PMID: 28527687 Free PMC article.
-
Opportunities for Typhoid Vaccination in India.Indian Pediatr. 2019 Jun 15;56(6):453-458. Indian Pediatr. 2019. PMID: 31278221 Review.
References
-
- Institute of Health Metrics and Evaluation. Global Burden of Disease. 2019. Available from ghdx.healthdata.org/gbd-results-tool accessed on November 14,2023.
-
- World Health Organization. Typhoid vaccines: WHO position paper–March 2018. Weekly Epidemiological Record No 13, 2018, 93, 153–172.
-
- IVAC. Viewhub. Typhoid Conjugate Vaccine. Introduction & Use. Available from https://view-hub.org/vaccine/typhoid accessed on 14 February 2024.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous